Youki Ueda[Author] - Search Results

Year	Number of Results
2011	1
2012	1
2013	3
2014	4
2015	2
2016	1
2017	2
2018	4
2019	4
2020	2
2021	2
2022	2
2023	4
2024	3

1

Activated CTLA-4-independent immunosuppression of Treg cells disturbs CTLA-4 blockade-mediated antitumor immunity.

Watanabe T, Ishino T, Ueda Y, Nagasaki J, Sadahira T, Dansako H, Araki M, Togashi Y. Watanabe T, et al. Among authors: ueda y. Cancer Sci. 2023 May;114(5):1859-1870. doi: 10.1111/cas.15756. Epub 2023 Feb 26. Cancer Sci. 2023. PMID: 36762794 Free PMC article.

2

[Clonal Evolution in the Tumor Microenvironment].

Ueda Y, Togashi Y. Ueda Y, et al. Gan To Kagaku Ryoho. 2022 Sep;49(9):907-913. Gan To Kagaku Ryoho. 2022. PMID: 36156003 Japanese.

3

Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration.

Morinaga T, Inozume T, Kawazu M, Ueda Y, Sax N, Yamashita K, Kawashima S, Nagasaki J, Ueno T, Lin J, Ohara Y, Kuwata T, Yukami H, Kawazoe A, Shitara K, Honobe-Tabuchi A, Ohnuma T, Kawamura T, Umeda Y, Kawahara Y, Nakamura Y, Kiniwa Y, Morita A, Ichihara E, Kiura K, Enokida T, Tahara M, Hasegawa Y, Mano H, Suzuki Y, Nishikawa H, Togashi Y. Morinaga T, et al. Among authors: ueda y. Cancer Res Commun. 2022 Jul 28;2(7):739-753. doi: 10.1158/2767-9764.CRC-22-0050. eCollection 2022 Jul. Cancer Res Commun. 2022. PMID: 36923281 Free PMC article.

4

Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies.

Kemmotsu N, Ninomiya K, Kunimasa K, Ishino T, Nagasaki J, Otani Y, Michiue H, Ichihara E, Ohashi K, Inoue T, Tamiya M, Sakai K, Ueda Y, Dansako H, Nishio K, Kiura K, Date I, Togashi Y. Kemmotsu N, et al. Among authors: ueda y. Int J Cancer. 2024 Jan 1;154(1):169-179. doi: 10.1002/ijc.34700. Epub 2023 Aug 23. Int J Cancer. 2024. PMID: 37611176

5

Stem-like progenitor and terminally differentiated T_FH-like CD4⁺ T cell exhaustion in the tumor microenvironment.

Zhou W, Kawashima S, Ishino T, Kawase K, Ueda Y, Yamashita K, Watanabe T, Kawazu M, Dansako H, Suzuki Y, Nishikawa H, Inozume T, Nagasaki J, Togashi Y. Zhou W, et al. Among authors: ueda y. Cell Rep. 2024 Feb 27;43(2):113797. doi: 10.1016/j.celrep.2024.113797. Epub 2024 Feb 15. Cell Rep. 2024. PMID: 38363680 Free article.

6

CD106 in tumor-specific exhausted CD8+ T cells mediates immunosuppression by inhibiting TCR signaling.

Naoi Y, Morinaga T, Nagasaki J, Ariyasu R, Ueda Y, Yamashita K, Zhou W, Kawashima S, Kawase K, Honobe-Tabuchi A, Ohnuma T, Kawamura T, Umeda Y, Kawahara Y, Nakamura Y, Kiniwa Y, Yamasaki O, Fukushima S, Kawazu M, Suzuki Y, Nishikawa H, Hanazawa T, Ando M, Inozume T, Togashi Y. Naoi Y, et al. Among authors: ueda y. Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-0453. Online ahead of print. Cancer Res. 2024. PMID: 38635899

7

Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activities.

Gu W, Ueda Y, Dansako H, Satoh S, Kato N. Gu W, et al. Among authors: ueda y. FASEB Bioadv. 2021 Mar 4;3(5):356-373. doi: 10.1096/fba.2020-00107. eCollection 2021 May. FASEB Bioadv. 2021. PMID: 33977235 Free PMC article.

8

Identification of ribavirin-responsive cis-elements for GPAM suppression in the GPAM genome.

Onomura D, Satoh S, Ueda Y, Dansako H, Kato N. Onomura D, et al. Among authors: ueda y. Biochem Biophys Res Commun. 2020 Nov 26;533(1):148-154. doi: 10.1016/j.bbrc.2020.08.112. Epub 2020 Sep 12. Biochem Biophys Res Commun. 2020. PMID: 32933750

9

Extracellular vesicles activate ATM-Chk2 signaling pathway through the intercellular transfer of mitochondrial DNA in HBV-infected human hepatocytes.

Dansako H, Ueda Y, Satoh S, Kato N. Dansako H, et al. Among authors: ueda y. FASEB J. 2021 Jun;35(6):e21680. doi: 10.1096/fj.202002678R. FASEB J. 2021. PMID: 34042225

10

Somatic mutations can induce a noninflamed tumour microenvironment via their original gene functions, despite deriving neoantigens.

Ishino T, Kawashima S, Tanji E, Ueno T, Ueda Y, Ogasawara S, Sato K, Mano H, Ishihara S, Kato N, Kawazu M, Togashi Y. Ishino T, et al. Among authors: ueda y. Br J Cancer. 2023 Apr;128(6):1166-1175. doi: 10.1038/s41416-023-02165-6. Epub 2023 Feb 2. Br J Cancer. 2023. PMID: 36732592 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

31 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year